Back
FibroGen Vs. Relmada Therapeutics Industry Stock Comparison
Buy
55
FGEN
FibroGen
Last Price:
$0.55
Seasonality Move:
1.68%
Sell
3
RLMD
Relmada Therapeutics
Last Price:
$0.40
Seasonality Move:
7.15%
Sell
3
Relmada Therapeutics (RLMD)
is a Sell
Is Relmada Therapeutics a Buy, Sell or Hold?
-
The current Relmada Therapeutics [RLMD] share price is $0.40. The Score for RLMD is 3, which is 94% below its historic median score of 50, and infers higher risk than normal.
-
RLMD is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
FGEN Stock Price Chart
RLMD Stock Price Chart
What is Relmada Therapeutics's stock price today?
-
The Relmada Therapeutics share price today is $0.40Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RLMD is experiencing slight selling pressure.
FGEN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.07 | Buy |
Relative Strength Index (14 RSI): | 61.8 | Buy |
Chaikin Money Flow: | -316926 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.35 - 0.59) | Buy |
Bollinger Bands (100): | (0.32 - 0.48) | Buy |
RLMD Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.32 | Sell |
Relative Strength Index (14 RSI): | 26.6 | Sell |
Chaikin Money Flow: | -88363 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.37 - 0.47) | Sell |
Bollinger Bands (100): | (1.22 - 3.7) | Sell |
FGEN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.59 | Sell |
20-day SMA: | 0.49 | Buy |
50-day SMA: | 0.41 | Buy |
200-day SMA: | 0.76 | Sell |
8-day EMA: | 0.59 | Sell |
20-day EMA: | 0.52 | Buy |
50-day EMA: | 0.46 | Buy |
200-day EMA: | 1.01 | Sell |
RLMD Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.45 | Sell |
20-day SMA: | 0.41 | Sell |
50-day SMA: | 1.72 | Sell |
200-day SMA: | 3.02 | Sell |
8-day EMA: | 0.44 | Sell |
20-day EMA: | 0.62 | Sell |
50-day EMA: | 1.4 | Sell |
200-day EMA: | 2.8 | Sell |
FibroGen Earnings Growth & FGEN Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.29 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.48 per share, and an increase next year of $0.18 per share.
Relmada Therapeutics Earnings Growth & RLMD Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.41 per share, and an increase next year of $0.39 per share.
FibroGen Technical Analysis
Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | Jan 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | 10 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Relmada Therapeutics Technical Analysis
Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | Jan 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | 10 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |